Brief: CanSino Biologics' Inhalable COVID Vaccine Obtains EUA In Indonesia
01/03/2023 10:58
March 1 (Reuters) - CanSino Biologics Inc 6185.HK :
* SAYS ITS INHALABLE COVID VACCINE OBTAINS EMERGENCY USE
AUTHORISATION (EUA) FROM INDONESIA'S FOOD AND DRUG REGULATOR
Source text
Further company coverage: 6185.HK
(Reporting by Hong Kong newsroom)
((meg.shen@thomsonreuters.com; 852-39525805;))
Recent news on Cansino Biologics
See all newsBrief: CanSino Biologics Says China's NMPA Granted Priority Review Status To NDA For TD5CP Adolescent, Adult
Brief: CanSino Biologics Reports Widened Net Loss For Q1
Brief: CanSino Biologics Says 2025 Net Profit At 27.9 Million Yuan
Brief: CanSino Biologics Prelim 2025 Net Profit At 27.9 Million Yuan
Brief: CanSino Biologics Expects To Have Returned to Net Profit In 2025